Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Falling Comet
1079.8000 -60.00 (-5.26%)
NSE Aug 01, 2025 15:31 PM
Volume: 2.0M
 

1079.80
-5.26%
Deven Choksey
Aurobindo Pharma’s wholly owned subsidiary, Aurobindo Pharma USA Inc., has entered into a definitive agreement with Lannett Seller Holdco, Inc. to acquire 100% membership interest in Lannett Company LLC.
Aurobindo Pharma Ltd. has an average target of 1447.50 from 10 brokers.
More from Aurobindo Pharma Ltd.
Recommended